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Insulin receptor was copurified from human placenta together with insulin-stimulated kinase activity that phosphorylates 
the insulin receptor on serine residues. Analysis of phosphorylated insulin receptor by two-dimensional tryptic peptide 
mapping showed that sites of insulin stimulated serine phosphorylation in the insulin receptor were recovered in the same 
peptides as those known to be phosphorylated on serine in vivo in response to insulin. This indicates that the serine kinase 
copurified with the insulin receptor epresents aphysiologically important enzyme involved in the insulin triggered serine 
phosphorylation of the insulin receptor in vivo. 
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1. INTRODUCTION 
The insulin receptor is an insulin-activated, 
tyrosine-specific protein kinase which catalyzes the 
autophosphorylation of multiple tyrosine residues 
in its own &subunit [l-7], and subsequently the 
phosphorylation of other proteins [8,9] (for a 
review see [lo]). In intact cells the insulin receptor 
is also well known to be phosphorylated on serine 
residues in response to insulin [l I-141. Most 
purified or partially purified preparations of the 
insulin receptor lack the serine kinase activity. 
Recently Smith et al. [15] have devised a protocol 
for isolating insulin receptor from human placen- 
tal membranes with associated insulin-sensitive 
serine kinase activity. This serine kinase activity 
appears to be a novel species and distinct from 
Ca2+/calmodulin, cyclic AMP and cyclic GMP- 
dependent protein kinases, casein kinases I and II 
and insulin-activated ribosomal S6 kinase [ 161. Us- 
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ing this system Smith and Sale [16] have shown 
that inhibition of the tyrosine kinase activity of the 
insulin receptor by nine different methods, in- 
cluding use of peptide 1142-1153 of the insulin 
receptor as a competing substrate and an- 
tiphosphotyrosine antibody which locks the 
tyrosine kinase in a low activity form, all inhibit 
the ability of insulin to stimulate phosphorylation 
of the insulin receptor on serine. Additionally, 
direct stimulation of the receptor tyrosine kinase 
by vanadate increases phosphorylation of the in- 
sulin receptor on serine. Moreover, insulin- 
stimulated tyrosine phosphorylation precedes 
insulin-stimulated serine phosphorylation of the 
placental insulin receptor in vitro. Taken together 
this indicates that activation by insulin of the 
receptor serine kinase activity depends on the 
tyrosine kinase activity of the insulin receptor [ 161. 
It is important to know whether the serine kinase 
that copurifies with the placental insulin receptor 
isolated by the protocol of Smith et al. [15] is one 
that acts on the insulin receptor physiologically. In 
the present work this has been investigated by 
characterizing the serine sites phosphorylated on 
the placental receptor in vitro by two-dimensional 
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thin-layer peptide mapping of tryptic phosphopep- 
tides and comparing them with those known to be 
phosphorylated in vivo. 
2. MATERIALS AND METHODS 
Insulin receptor was isolated with associated insulin-sensitive 
serine kinase activity by solubilization of human placental 
membranes in 2% Triton X-100 followed by chromatography 
on wheat-germ-agglutinin-agarose u ing the protocol of Smith 
et al. [15]. Cellulose thin-layer plates (20 x 20 cm) were from 
Kodak, Kirkby, Liverpool, England. Sources of other materials 
were as described in [15,16]. 
2. I. Phosphorylation of insulin receptor and preparation of 
tryptic phosphopeptides 
Insulin receptor (1 mg protein/ml) was incubated for 15 min 
at 22°C with or without 150 nM insulin in 30~1 of 50 mM 
Hepes (pH 7.4)/O. 1% Triton X-100 in the presence ‘of 10 mM 
MgClz, 2 mM MnClz, 1 mM dithiothreitol and 30 FM sodium 
vanadate, [y-‘*P]ATP (100 ,uM; 15 cpm/fmol) was then added, 
and after incubation for a further 15 min at 22°C phosphoryla- 
tions were terminated by adding Laemmli 1171 sample buffer 
(62.5 mM Tris-HCI, pH 7.4, 1”lo (w/v) SDS, 19 mg/ml 
dithiothreitol, 0.002% (w/v) bromophenol blue, 20% (w/v) 
sucrose) and boiling for 2 min [15]. Insulin receptor &subunits 
were separated on 4% acrylamide stacking/7.5% acrylamide 
resolving gels and located by autoradiography 1151. The region 
of the gel containing the&subunit was excised, counted in 5 ml 
of scintillation fluid [5-(4-biphenylyl)-2-(4t-butylphenyl) 
I-oxa-3,4-diazole (6 g/l) in toluene], incubated with 10 ml of 
20% (v/v) methanol for 18 h at 37°C and dried at 70°C for 2 h 
in an oven. Then 2 ml of 50 mM NHdHCOp containing 100 pg 
of trypsin (treated with tosylphenylalanylchloromethane) was 
added. The mixture was incubated at 37°C for 6 h, a further 
100 cg of trypsin was added and incubation continued for a fur- 
ther 18 h. The samples were freeze dried and either subjected to 
phosphoamino acid analysis as described in [15] or two- 
dimensional thin-layer peptide mapping. 
2.2. Two-dimensional thin-layer peptide mapping 
The 32P-labelled tryptic phosphopeptides were dissolved in 
20 ~1 of water and separated on a cellulose thin-layer plate by 
electrophoresis at 400 V for 4 h at pH 3.5 (pyridine/acetic 
acid/water, 1: 10: 189 by vol.) in the first dimension and ascen- 
ding chromatography (pyridine/acetic acid/butanol/water, 
10:3: 15: 12, by vol.) in the second dimension [6]. 
Autoradiograms were obtained at -70°C for 2-7 days using 
Amersham Hyperfilm-MP (Amersham International, Bucks, 
England) within cassettes containing DuPont Cronex intensifier 
screens. 32P associated with phosphopeptides was determined 
by densitometric scanning with a Joyce-Loebl Chromoscan 3. 
For phosphoamino acid analysis of tryptic phosphopeptides 
purified by two-dimensional thin-layer analysis, the peptides 
were removed by scraping the cellulose and hydrolyzed in 6 M 
HCl at 110°C for 2 h. Phosphoamino acids were separated by 
electrophoresis on cellulose thin-layer plates at pH 3.5 for 1.5 h 
at 1 kV [15]. 
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3. RESULTS AND DISCUSSION 
Insulin receptor was copurified with associated 
insulin-stimulated insulin receptor serine kinase ac- 
tivity by the protocol of Smith et al. [ 151. This in- 
volved solubilization of human placental 
membranes in Triton X-100 and affinity 
chromatography on wheat-germ-agglutinin-aga- 
rose. The insulin receptor was phosphorylated with 
[T-~~P]ATP in the presence or absence of insulin 
and subjected to SDS gel electrophoresis. 
Phosphorylation of the P-subunit of the insulin 
receptor on tyrosine and serine was stimulated by 
insulin 4-5-fold and 6-7-fold, respectively, for 
preparations used in this study. Isolation of the ,&- 
subunits and direct phosphoamino acid analysis 
gave phosphoserine/phosphotyrosine ratios of ap- 
prox. 0.2 for insulin receptor phosphorylated in 
the presence of insulin. These values are similar to 
those previously obtained using the placental in- 
sulin receptor preparation [ 15,161. 
&Subunits isolated from insulin receptor 
phosphorylated in the presence of insulin were 
digested with trypsin and subjected to two- 
dimensional thin-layer peptide mapping (fig. la). 
32P-labelled tryp tic phosphopeptides resolved by 
two-dimensional peptide mapping were scraped 
off and their phosphoamino acid content deter- 
mined (table 1). Upon thin layer analysis a com- 
plex pattern of phosphopeptides was obtained. 
This arises because insulin-stimulated phos- 
phorylation of the &subunit occurs on at least 
seven tyrosines as well as on serine or serines [3-71. 
The tyrosines are clustered in three domains: 
tyrosines 13 16, 1322 in the C-terminal tail; 1146, 
1150 and 115 1 in the tyrosine kinase domain and 
possibly 953 and 960 or 972 near the transmem- 
brane domain. Sites of insulin-stimulated serine 
phosphorylation have not been localized. Addi- 
tionally, certain peptides are incompletely cleaved 
by trypsin, despite exhaustive digestion, adding 
further to the complexity. The identities of 32P- 
labelled tryptic phosphotyrosyl peptides resolved 
by two-dimensional thin-layer mapping have been 
determined by Tavare and Denton [6] and these 
assignments are used in the key to fig. 1. The posi- 
tions of the major phosphotyrosyl peptides re- 
solved in the present work, using the 
autophosphorylated placental insulin receptor, 
correspond exactly with those obtained by Tavare 
Volume 242, number 2 FEBS LETTERS January 1989 
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Fig. 1. Two-dimensional thin-layer peptide mapping of 
phosphorylated insulin receptor. Insulin receptor with 
associated insulin stimulated serine kinase activity was partially 
purified from human placental membranes and phosphorylated 
with [y-“P]ATP in the presence of insulin. The b-subunits of 
the insulin receptor were isolated by SDS gel electrophoresis, 
digested with trypsin and 32P-labelled tryptic phosphopeptides 
separated on a cellulose thin-layer plate by electrophoresis at 
pH 3.5 and ascending chromatography. (a) An autoradiograph 
of the result which is representative of several experiments on 
different preparations of the insulin receptor. The origin of 
sample application is marked by an arrow. (b) A key to the 
identification of the ‘*P-labelled phosphopeptides. 
Phosphotyrosyl peptides are: Cl, 1143-1153, mixture of 
monophosphorylated forms; B2, 1143-l 156 and B3. 
1143-l 153, mixture of diphosphorylated forms; Al, 
1143-l 156 and A2, 1143-1153, triphosphorylated; Bl, 
1315-1329, diphosphorylated; Cl ‘, C2 and C3 are believed to 
be phosphorylated at tyrosine residues 953 and 960 or 972 [6,7]. 
C2 and C3 are barely evident. Phosphoserine is predominantly 
recovered in peptides labelled S and also the Cl/Cl’ region 
(table 1). These phosphoseryl peptides correspond to those 
derived from insulin receptor phosphorylated in vivo. A small 
amount of phosphoserine is also recovered in peptides Ul and 
U2. The identities of Ul, U2, U3, U4 and phosphopeptides not 
illustrated in the key are unknown. 
Table 1 
Phosphoamino acid analysis of 32P-labelled tryptic 
phosphopeptides separated by two-dimensional thin-layer 
peptide mapping 
Peptide ‘*P (arbitrary units) 
Total Phosphotyrosine Phosphoserine 
Al 27.7 + 6.7 27.7 f 6.7 0.0 f 0.0 
A2 28.7 f 5.2 28.7 f 5.2 0.0 f 0.0 
Bl 35.3 + 6.5 35.3 f 6.5 0.0 f 0.0 
B2 2.3 f 0.3 ND ND 
B3 29.7 + 5.2 29.7 + 5.2 0.0 * 0.0 
Cl’ 13.7 + 0.7 8.0 + 0.6 5.7 + 0.9 
Cl 14.3 f 2.0 8.3 + 1.8 6.0 f 0.6 
c2 3.7 + 1.4 ND ND 
c3 1.3 f 0.7 ND ND 
S (upper) 16.7 + 1.5 7.7 + 0.9 9.0 f 0.6 
S (lower) 15.7 f 1.2 6.3 f 0.3 9.3 * 0.9 
Ul 6.3 * 2.4 5.7 + 2.2 0.6 it 0.2 
u2 6.8 + 1.6 5.7 * 1.2 1.1 * 0.5 
u3 15.7 f 2.6 15.7 f 2.6 0.0 + 0.0 
u4 9.3 + 5.3 9.3 + 5.3 0.0 f 0.0 
Human placental insulin receptor copurified with insulin- 
stimulated serine kinase activity was phosphorylated with 
[y-‘*P]ATP in the presence of insulin. The &subunits of the 
insulin receptor were isolated, digested with trypsin and 
subjected to two-dimensional thin-layer analysis. 32P-labelled 
tryptic phosphopeptides were located by autoradiography and 
subjected to phosphoamino acid analysis. Total “P present in 
the various phosphopeptides and 32P recovered in 
phosphoamino acids was quantitated by densitometric scanning 
of autoradiographs. Values are means f SE for 3 thin layer 
analyses. ND, not determined 
and Denton [6] and TavarC et al. [7] who used 
autophosphorylated insulin receptors from human 
placenta, CH0.T cells and NIH 3T3 HIR3.5 cells. 
Using both intact CH0.T cells and NIH 3T3 
HIR 3.5 cells the in vivo site(s) of insulin- 
stimulated serine phosphorylation were shown by 
Tavare et al. [7] to be recovered in peptide that 
resolved poorly from monophosphotyrosyl peptide 
1143-1153 (Cl). This resulted in phosphoserine 
being detected in the Cl spot as well as 
phosphopeptide(s) designated S which migrated to 
a position that overlapped with the right hand side 
of the Cl spot [7]. This distinctive pattern was also 
obtained upon analysis of placental insulin recep- 
tor copurified with serine kinase activity and 
phosphorylated in vitro in the presence of insulin 
(fig.la, table 1). This indicates that the serine 
kinase that associates with the insulin receptor 
during purification by the protocol of Smith et al. 
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[15] is active on the insulin receptor in vivo. Addi- 
tionally, in the present work resolution in the 
chromatography direction of the thin-layer 
analysis was better than that obtained by Tavare et 
al. [7] and phosphoseryl peptide S more clearly 
separated into two peptides. Moreover both S 
spots and the Cl spot contained phosphotyrosine 
and phosphoserine (phosphoserine/phosphotyro- 
sine ratios: S (upper) = 1.2; S (lower) = 1.5; Cl = 
0.72) as found for S and Cl derived from insulin 
receptor phosphorylated in vivo [7]. The Cl ’ spot 
obtained from placental insulin receptor 
phosphorylated in vitro also contained both 
phosphoserine and phosphotyrosine (phospho- 
serine/phosphotyrosine ratio = 0.71); Cl’ ob- 
tained from insulin receptor phosphorylated in 
vivo was not analyzed [7]. There appear to be two 
possible explanations for the presence of phospho- 
tyrosine and phosphoserine in the same spots. 
Firstly, phosphoserine and phosphotyrosine could 
reside in distinct phosphopeptides that are in- 
completely resolved. Secondly, phosphoserine and 
phosphotyrosine could be present within the same 
peptide. It is noteworthy that phosphotyrosyl pep- 
tides derived from both the C-terminal domain 
(contains tyrosine residues 1316, 1322) and the 
juxtamembrane domain (contains tyrosine residues 
950 and 960 or 972) contain serine residues. The 
juxtamembrane domain has been postulated to 
contain a serine site phosphorylated by Ca’+/phos- 
pholipid-dependent protein kinase [ 181. 
In the present study spots S, Cl and Cl’ ac- 
counted for > 90% of the phosphoserine recovered 
after two-dimensional mapping of tryptic 
phosphopeptides derived from placental insulin 
receptor phosphorylated in vitro in the presence of 
insulin. Further study is required to determine 
whether this actually represents phosphorylation 
of more than one serine site. The remainder of the 
phosphoserine was located in two minor spots, Ul 
and U2. Phosphoserine was barely detected when 
insulin receptor was phosphorylated in the absence 
of insulin. Additionally two phosphotyrosyl pep- 
tides labelled U3 and U4 were resolved in the pre- 
sent work that was not discernible in the studies of 
TavarC and co-workers [6,7]. The detection of U3 
could again reflect the greater resolution achieved 
in this study in the chromatographic direction. U4 
was relatively minor. 
In conclusion the specific copurification of the 
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insulin receptor with a serine kinase activity, the 
insulin-dependent nature of the activation of the 
serine kinase and the ability of the copurified 
serine kinase to phosphorylate in vitro serines in 
the same peptides that are phosphorylated in vivo 
all indicate that the serine kinase copurified with 
the placental insulin receptor is a physiologically 
relevant kinase involved in the insulin triggered 
serine, phosphorylation of the insulin receptor in 
vivo. 
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